6ER-008 Development of a risk-sharing model based on the clinical performance of onasemnogene abeparvovec (Zolgensma)
Autor: | AC Martins De Figueiredo, RP Pinheiro Gonçalves Marques, AP Mecheiro De Almeida Martins Silvestre Correia, AF Cosme Silva |
---|---|
Rok vydání: | 2022 |
Zdroj: | Section 6: Education and research. |
DOI: | 10.1136/ejhpharm-2022-eahp.358 |
Databáze: | OpenAIRE |
Externí odkaz: |